About Pulnovo Medical
Pulnovo Medical is a company based in Wuxi (China) founded in 2013.. Pulnovo Medical has raised $115.46 million across 3 funding rounds from investors including Orbimed, Qiming Venture Partners and Lilly Asia Ventures. Pulnovo Medical operates in a competitive market with competitors including SoniVie, BTG International, Aria CV, Adient Medical and Crux Biomedical, among others.
- Headquarter Wuxi, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$115.46 M (USD)
in 3 rounds
-
Latest Funding Round
$100 M (USD), Series C
Mar 02, 2025
-
Investors
Orbimed
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pulnovo Medical
Pulnovo Medical has successfully raised a total of $115.46M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $100.0M
-
First Round
First Round
(04 Aug 2021)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series C - Pulnovo Medical | Valuation | Qiming Venture Partners , Lilly Asia Ventures | |
| Nov, 2022 | Amount | Series A - Pulnovo Medical | Valuation | Yuanbio Venture Capital | |
| Aug, 2021 | Amount | Series A - Pulnovo Medical | Valuation | JI Capital Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pulnovo Medical
Pulnovo Medical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Qiming Venture Partners and Lilly Asia Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Investments in biomedical companies are directed by Lilly Asia Ventures.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pulnovo Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pulnovo Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pulnovo Medical Comparisons
Competitors of Pulnovo Medical
Pulnovo Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SoniVie, BTG International, Aria CV, Adient Medical and Crux Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A denervation catheter for pulmonary hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.
|
|
| domain | founded_year | HQ Location |
Device for pulmonary hypertension
|
|
| domain | founded_year | HQ Location |
Bioabsorbable medical devices are developed for pulmonary embolism prevention.
|
|
| domain | founded_year | HQ Location |
Retrievable vena cava filters are developed to prevent pulmonary emboli.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pulnovo Medical
Frequently Asked Questions about Pulnovo Medical
When was Pulnovo Medical founded?
Pulnovo Medical was founded in 2013 and raised its 1st funding round 8 years after it was founded.
Where is Pulnovo Medical located?
Pulnovo Medical is headquartered in Wuxi, China. It is registered at Wuxi, Jiangsu, China.
Who is the current CEO of Pulnovo Medical?
Jessie Lian is the current CEO of Pulnovo Medical.
Is Pulnovo Medical a funded company?
Pulnovo Medical is a funded company, having raised a total of $115.46M across 3 funding rounds to date. The company's 1st funding round was a Series A of $15.46M, raised on Aug 04, 2021.
What does Pulnovo Medical do?
Pulnovo Medical was founded in 2013 in Wuxi, China, within the medical devices sector. Focus is placed on developing the PADN multipolar synchronous pulmonary artery radiofrequency ablation catheter. This device transmits high-frequency current to ablate the pulmonary sympathetic nerve, addressing pulmonary hypertension. Operations center on innovation in cardiovascular treatments, with activities based in China to support global healthcare needs.
Who are the top competitors of Pulnovo Medical?
Pulnovo Medical's top competitors include SoniVie, BTG International and Aria CV.
Who are Pulnovo Medical's investors?
Pulnovo Medical has 10 investors. Key investors include Orbimed, Qiming Venture Partners, Lilly Asia Ventures, Gaorong Capital, and BioVenture.